Matinas BioPharma Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders Equity

Consolidated Statement of Stockholders Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Redeemable Convertible Preferred Stock [Member]
Balance at Dec. 31, 2012	$ (116,592)us-gaap_StockholdersEquity	$ 1,000	$ 0	$ (117,592)	$ 456,528
Balance (in Shares) at Dec. 31, 2012		10,000,000			925,926
Sale of Preferred Stock					500,001
Sale of Preferred Stock (in Shares)					925,926
Issuance cost paid in connection of sale of preferred stock					(4,140)
Formation of Matinas BioPharma Holdings (July 11, 2013)	375,000	750	374,250
Formation of Matinas BioPharma Holdings (July 11, 2013) (in Shares)		7,500,000
Elimination of Matinas BioPharma Inc. Equity (July 11, 2013)	(1,000)	(1,000)			(952,389)
Elimination of Matinas BioPharma Inc. Equity (July 11, 2013) (in Shares)		(10,000,000)			(1,851,852)
Issuance of shares in Matinas Holdings to former shareholders of Matinas BioPharma Inc	953,389	900	952,489
Issuance of shares in Matinas Holdings to former shareholders of Matinas BioPharma Inc (in Shares)		9,000,000
Sale of warrants	138,316		138,316
Private Placement ( July 30, 2013 and August 8, 2013)	15,000,000	1,500	14,998,500
Private Placement ( July 30, 2013 and August 8, 2013) (in Shares)		15,000,000
Private Placement Issuance Costs	(2,378,672)		(2,378,672)
Restricted Stock Grant to non-employee	470,000	50	469,950
Restricted Stock Grant to non-employee (in Shares)		500,000
Restricted Stock for services to be rendered	(463,562)		(463,562)
Stock Based Compensation	211,036		211,036
Net loss	(3,713,127)us-gaap_NetIncomeLoss			(3,713,127)
Balance at Dec. 31, 2013	10,474,788us-gaap_StockholdersEquity	3,200	14,302,307	(3,830,719)	0
Balance (in Shares) at Dec. 31, 2013		32,000,000			0
Stock Based Compensation	1,821,402		1,821,402
Issuance of Common Stock for services	152,721	30	152,721
Issuance of Common Stock for services (in Shares)		292,650
Net loss	(10,221,045)us-gaap_NetIncomeLoss			(10,221,045)
Balance at Dec. 31, 2014	$ 2,227,896us-gaap_StockholdersEquity	$ 3,230	$ 16,276,430	$ (14,051,764)	$ 0
Balance (in Shares) at Dec. 31, 2014		32,292,650			0